Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 339047

AbstractMaterial and MethodsResultsDiscussionConclusionAcknowledgementReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2022 | Month : February | Volume : 16 | Issue : 2 | Page : SC23 - SC27 Full Version

Blood Lactate Levels and PRISM III Scores for Prognosis of Shock during Paediatric Emergencies: A Prospective Observational Cross-sectional Study


Published: February 1, 2022 | DOI: https://doi.org/10.7860/JCDR/2022/50903.16006
S Sri Raksha, J Krishnappa, KN Shashidhar

1. Senior Resident, Department of Paediatrics, Sri Devaraj URS Medical College, Kolar, Karnataka, India. 2. Professor, Department of Paediatrics, Sri Devaraj URS Medical College, Kolar, Karnataka, India. 3. Professor, Department of Biochemistry, Sri Devaraj URS Medical College, Kolar, Karnataka, India.

Correspondence Address :
Dr. J Krishnappa,
Professor, Department of Paediatrics, Sri Devraj URS Medical College,
Tamaka, Kolar-563101, Karnataka, India.
E-mail: drjkgowda@gmail.com

Abstract

Introduction: The appropriate management of shock in paediatrics includes early recognition of tissue hypoxia and its timely intervention thus preventing shift to anaerobic metabolism, metabolic acidosis and cell death.

Aim: To determine the effectiveness of blood lactate levels as a prognostic indicator of mortality in children with shock admitted to Paediatric Intensive Care Unit (PICU) and to correlate between blood lactate levels and Paediatric Risk of Mortality III (PRISM III) scores.

Materials and Methods: This was a prospective observational cross-sectional study conducted between January 2018 to May 2019 in the PICU of a tertiary care centre in rural India. A total of 144 children presenting with shock to PICU were included in the study. The serum lactate values were assessed at 0, 12 and 24 hours of admission. The various parameters of PRISM III scores was documented for each child at 0, 12 and 24 hours of admission and score was calculated. Lactate levels and PRISM III score were analysed using the Receiver Operating Characteristic (ROC) curve and optimal cut-off points were chosen for the calculation of sensitivity, specificity, positive and negative predictive values. An area under the ROC curve above 0.8 indicated fairly good prediction.

Results: The most common aetiologies for shock in the present study included severe sepsis (42.3%), acute gastroenteritis (21.5%) and dengue fever (21.5%). Persistent hyperlactatemia was observed in non survivors and serum lactate values persistently greater than 4 mmol/L within the first 24 hours of admission were associated with greater risk of mortality. The area under the ROC curve for the serum lactate levels (0.958) suggested that, it was a strong predictor of mortality in study subjects when compared to PRISM III score which had area under the ROC curve 0.866.

Conclusion: Serum lactate values are an early useful predictor of mortality in children with shock and it is more feasible indicator when compared to PRISM III scores.

Keywords

Metabolic acidosis, Mortality, Paediatric risk of mortality III scores, Sepsis, Tissue hypoxia

Shock is one of the most frequent life-threatening conditions which is encountered in Paediatric Intensive Care Unit (PICU). Shock is an acute process characterised by the body’s inability to deliver adequate oxygen to meet the metabolic demands of vital organs and tissues (1),(2). Hypoxia at the tissue level is unable to support normal aerobic cellular metabolism and shift to the less efficient anaerobic metabolism. When there is an imbalance between oxygen delivery to the tissue and oxygen requirement there is oxygen debt which leads to progressive clinical deterioration and lactic acidosis (3),(4).

The appropriate management of shock in paediatrics includes early recognition of tissue hypoxia and its timely intervention thus preventing shift to anerobic metabolism, metabolic acidosis and cell death (5),(6),(7). Early indicators of mortality in paediatric patients with shock can be employed to assess and determine the risk of mortality so that early intervention can be followed in order to prevent adverse events (8),(9),(10).

Lactic acid is a metabolite generated as a result of anaerobic glycolysis (11),(12). Hyperlactatemia is a very important cardinal finding in paediatric shock. The mechanism of hyperlactatemia has two pathways, one in sepsis and the other one in cases of septic shock (13),(14). In case of sepsis, an increase in lactate levels implies increased glycolysis due to increase in metabolic rate and in cases of shock, the raised glycolytic flux is due to tissue hypoxia. Thus, this implies that there are two varieties of lactate that is “stress lactate” and “shock lactate” (15),(16),(17). This lactic acid, thus, estimated can be used as a marker for predicting the outcome of patients in shock.

The paediatric risk of mortality score is one of the most important indicators that is used in the Paediatric ICU. It provides a good discriminatory performance and prediction; it is extensively used in many Paediatric ICUs as a prognostic score to assess gravity of disease (18),(19).

The PRISM III scores were developed based on the parameters of PRISM scores with modifications and improvements. The physiological variable and ranges have been revaluated. Predictive power of various physiological variables was reassessed and those that did not contribute significantly to mortality were eliminated (18). Using a scoring system which is practical and more objective, so as to provide clinical and/or laboratorial criteria to evaluate if, any delay in treatment is an important factor of impact on quality of care in critically ill patients. The ideal score is the one which should be easy to use, easy to reproduce, low cost, minimally invasive and accurate (19),(20),(21). In the present study, study is intended to know relation between serum lactate levels and the outcome of the patient and to correlate the same with the PRISM III scores.

Material and Methods

A prospective observational cross-sectional study was conducted for a duration of one year four months from January 2018 to May 2019. A total of 144 patients were included in the present study. All the patients with shock , between the age group of one month and 18 years who were admitted to PICU in RL Jalappa Hospital and Research Centre, Kolar, Karnataka, India. Ethical Clearance Approval Number No. SDUMC/KLR/IEC/32/2017-2018 Dated:29-11-2017.

Inclusion criteria: All patients with shock, between the age group of one month and 18 years who were admitted to PICU were included. Shock in any phase that is compensated (Tachycardia, tachypnoea, normal or low urine output, normal or slightly elevated BP), decompensated phase (Altered sensorium, cool clammy extremities, blood pressure <-2 SD adjusted for age, oliguria, tachycardia, tachypnoea) and irreversible shock (comatose, cold cyanotic mottled extremities, not recordable BP, anuria, tachycardia, respiratory failure), were included.

Exclusion criteria: If the child died within <2 hours after admission or referred to other hospitals or discharged against medical advise.

Sample size calculation: Sample size was estimated based on the study conducted by Choudhary J et al., on the effectiveness of predicting outcome in critically ill children presenting in septic shock by assessing serum lactate levels (3). The required sample size was 144.

Study Procedure

All patients with shock between age group of one month and 18 years irrespective of aetiology were included in the present study after detailed clinical evaluation and diagnosis The patients at admission were evaluated clinically based on the physiologic variables in the PRISM III score. Arterial and venous blood was drawn for routine investigations necessary for evaluating the patients. The clinical status, co-morbidities, therapeutic interventions and medications were recorded daily until discharge or death.

PRISM III Score Parameters (20),(21): Total PRISM III Score: (Cardiovascular and neurologic subscore)+(acid base and blood gas subscore)+(Chemistry subscore)+(haematologic subscore).

The higher the total score the higher is the mortality. A rising score indicates deterioration. Blood Lactate was analysed by colorimetric method (Table/Fig 1).

The VITROS LAC Slide method was performed which is a multilayered analytical element coated on a polyester support. Lactate in the sample is oxidised by lactate oxidase to pyruvate and hydrogen peroxide. The hydrogen peroxide generated oxidises the 3-aminoantipyrene, 1,7-dihydroxynaphthalene dye system in a horseradish-peroxidase-catalysed reaction and results in a dye complex (12),(13),(14),(15). The test is a colorimetric method the incubation period is five minutes at a temperature of 37°C at a wavelength of 540 nm. The volume of the sample required is 10 microliters. The measuring range is 0.5-12 mmol/L. Blood lactate levels was estimated at admission and at 12 and 24 hours. The PRISM III score and serum lactate values were correlated.

Statistical Analysis

The collected data was entered into Microsoft Excel data sheet. This data was analysed using SPSS 22.0 version software. Categorical data was represented in the form of frequencies and proportions. The test of significance for qualitative data was determined using Chi-square test or Fischer’s-Exact test (for 2×2 tables only, the data has been modified). Continuous data was represented as mean and standard deviation. Independent t-test was used as test of significance to identify the mean difference between two quantitative variables. Lactate levels and PRISM III score were further analysed using the ROC and optimal cut-off points were chosen for the calculation of sensitivity, specificity, positive and negative predictive values. A test that predicts an outcome no better than chance has an area under the ROC curve of 0.5. An area under the ROC curve above 0.8 indicated fairly good prediction. The relationship of lactate at admission with the PRISM III score was determined by calculating the Spearman’s correlation co-efficient and two-tailed significance. The p-value (probability that the result is true) of <0.05 was considered as statistically significant after assuming all the rules of statistical tests.

Results

The most common aetiology in children who presented with shock in the present study was sepsis in septic shock. Bronchopneumonia was the most common aetiology of septic shock. About 42% of the children had septic shock (Table/Fig 2). Most children presented with warm shock and hyperdynamic circulation. However, few children presented with cold shock. Of the total 42 cases, blood culture and sensitivity revealed growth of organism in 28 cultures. The organism which was isolated includes Enterococcus, Klebsiella Pneumonia, Staphylococcus aureus, Acinetobacter species and Pseudomonas aeruginosa. The other cases had positive septic screen.

The second most common aetiology for shock was acute gastroenteritis with severe dehydration. A 31% of the children studied had AGE with severe dehydration. A total of 19 (13.2%) children presented with dengue fever with warning signs and 12 children had severe dengue fever (8.3%). Children with dengue fever with warning signs presented with hypotension (compensated shock), thrombocytopenia, excessive vomiting, pain abdomen. These children were in the compensated phase and responded to fluid resuscitation. Children with severe dengue fever presented with acute respiratory distress syndrome, dengue hepatitis, dengue haemorrhagic fever. Dengue encephalitis and multiorgan dysfunction syndrome. Fourteen (9.7%) children presented with diabetic ketoacidosis, out of which 10 cases were newly diagnosed type I diabetes and four cases were old cases of Type 1 diabetes with poor compliance to insulin therapy. All 14 children presented with severe diabetic ketoacidosis. The various other aetiologies for shock include, OP compound poisoning, submersion injury, late presentation of consumption of rat poison (zinc phosphide), and pubertal menorrhagia (Table/Fig 2).

As it can be observed the serum lactate values in survivors at time of admission was very much lower in comparison to non survivors at the time of presentation. There is progressive reduction in serum lactate values in survivors. Serum lactate values of non survivors at presentation were elevated significantly when compared to survivors. In non survivors, there is persistent hyperlactatemia even following resuscitation. Thus, concluding that high serum lactate values at presentation (according to the present study lactate values above 4 mmol/L) and persistent hyperlactatemia are associated with increased mortality.

There was a statistically significant difference found between survivors and non survivors with respect to serum lactate levels at all the time intervals intervals (Table/Fig 3).

The PRISM III values measured at admission in survivors was low and there was progressive reduction in the PRISM III scores. The PRISM III scores in non survivors was found to be elevated at presentation when compared to non survivors and there is increase in the scores at 12 hours of admission in non survivors. A persistently elevated scores above 20 was found to be associated with increase in the risk of mortality among children with shock shock (Table/Fig 4). There was a statistically significant difference found between survivors and non survivors with respect to PRISM III score at all the time intervals. A highly significant positive correlation existed between the PRISM III score and lactate level at admission (r=0.678; p-value <0.001) (Table/Fig 5).

The area under the ROC curve for the serum lactate levels (0.958) suggests that, it was a strong predictor of mortality in study subjects when compared to PRISM III score which had area under the ROC curve 0.866. Area under the ROC curve for both PRISM III score and serum lactate levels had a significant p-value <0.001) (Table/Fig 5).

This is the ROC curve for the PRISM III scores. The x-axis depicts specificity (true negative rate) rate and the y-axis depicts the sensitivity (true positive rate). From this ROC curve, it can be seen that the sensitivity of the PRISM III scores, that is the ability of the PRISM III scores to truly identify the children in shock who have poor prognosis and higher risk of mortality above the value of 17 is 83.7% and the specificity of PRISM III scores to identify the children who are not at the risk of mortality is 78.2% (Table/Fig 6).

This is the ROC curve for the serum lactate values. The x-axis depicts specificity (true negative rate) rate and the y-axis depicts the sensitivity (true positive rate). From this curve, it can be seen that sensitivity of the serum lactate values, that is ability of the serum lactate values to truly identify the children in shock who have poor prognosis and higher risk of mortality above the value of 3.7 is 93% and specificity of serum lactate values to identify the children who are not at risk of mortality is 94.1% (Table/Fig 7).

It was observed that blood lactate values were found to be important useful tool in predicting mortality in patients in shock, the values achieved AUC of 0.958 with standard error of 0.0171 with 95% confidence interval between 0.911-0.984. Many studies done previously have demonstrated that lactate values at admission or peak lactate values at any given time of admission is associated with mortality in adults. However, a very few studies have been conducted in children and demonstrated the use of hyperlactatemia as a prognostic indicator of mortality in critically ill children in PICU.

In the present study, serum lactate values have been correlated to PRISM III scores and compared as to which is a better indicator in predicting mortality in children presenting with shock. The PRISM III score is a good valid measure of illness severity of the critically ill children during the initial 24 hours of admission. It reflects on overall clinical picture of the child. It is the sum total of the physiological, biochemical and haematological parameters assessed. The PRISM III scores in non survivors were found to be elevated at presentation when compared to non survivors and there is increase in the scores at 12 hours of admission in non survivors. A persistently elevated scores above 20 was found to be associated with increase in the risk of mortality among children with shock.

The AUC for PRISM III scores was 0.866 with standard error of 0.0357 with 95% confidence interval of 0.799 to 0.917. Area under ROC curve was compared between serum lactate values and PRISM III scores. Area under ROC curve for serum lactate values was found to be 0.958 and area under ROC curve for PRISM III score was 0.866. Hence, this proves that serum lactate values are better predictors of mortality when compared to PRISM III score. Area under ROC curve for PRISM III score and serum lactate levels had a significant p-value <0.001. In the present study, sensitivity and specificity of serum lactate values and PRISM III scores was determined along with positive predictive values and negative predictive values. Using this data ROC curve was plotted. Also, optimal cut-off values were obtained for determining mortality.

A total of 75% of the children included in the present study had a blood lactate concentration of >2.5mmol/l at presentation. Blood lactate values had a sensitivity of 95.5% and specificity of 82.18% at values greater than 3.5 mmol/L with a PPV of 69.5 and NPV of 97.6 and at values >3.7 blood lactate values had a sensitivity of 93% and specificity of 94.5% with a PPV of 87 and NPV of 96.9. Overall any blood lactate values above 4 mmol/L within initial 24 hours of admission even after extensive resuscitation indicated very poor prognosis and higher risk of in hospital mortality.

The above analysis was compared with PRISM III scores which at values greater than 15 had a sensitivity of 88.37% and a specificity of 72.28% with PPV of 57.6 and NPV of 93.6 and at values greater than 17 it displayed a sensitivity of 95.35% and a specificity of 78.22% with a PPV of 62.1 and a NPV of 91.9. And it was observed that a PRISM III score of greater than 20 at any given time of admission within initial 24 hours indicates poor prognosis and carries a higher risk of mortality (Table/Fig 8).

Discussion

The present study was compared to a study done by Bai Z et al., in assessing blood lactate levels as prognostic indicator in critically ill children admitted to PICU (2). Median blood lactate levels were found to be 3.2 mmol/L (2.2-4.8 mmol/L). This study showed that elevated blood lactate levels at admission was associated with greater risk of mortality while the present study correlated PRISM III scores and serum lactate values, Morris KP et al., others conducted a retrospective cohort study in PICU to investigate whether blood lactate concentration on admission predicts mortality in PICU and if its addition can improve the performance of the Paediatric Index of Mortality 2 (PIM2) mortality prediction score and also to compare as to which is a better predictor of mortality (5). It was observed that the admission lactate in non survivors was higher than in survivors, had a positive association with mortality and significantly improved the model fit of PIM2 when it replaced absolute base excess. While in the present study, PRISM III scores were used instead of PIM2 scores. In both the studies, the mortality scores were correlated with serum lactate values to find out which was better as a prognostic indicator. Both PRISM III scores and serum lactate levels were found to be good indicators of mortality.

Another similar study was conducted by Jat KR et al., (12). This study was conducted to assess serum lactate values as prognostic indicator of mortality in children admitted to PICU with septic shock. It was observed that the initial as well as the subsequent lactate values were higher in the non survivors when compared to survivors. They correlated serum lactate values with PRISM III scores and observed that highly positive correlation existed between serum lactate and PRISM III scores. A PRISM III score greater than 10 and a lactate values greater than 5 mmol/L at all time periods discriminated survivors from non survivors. This study was similar to the present study, where PRISM III scores were correlated to serum lactate values as prognostic indicator in children admitted with shock. Similar to the above study, in the present study it was found that highly positive correlation existed between serum lactate and PRISM III scores. In the present study, as compared to the above study, it was found that a persistently elevated PRISM III values above 20 and serum lactate values above 4 mmol/L at all periods of time was a poor prognostic indicator.

Kim YA et al., conducted a retrospective study on paediatric patients presenting with septic shock at Seoul Korea (1). A total of 65 patients were enrolled and overall mortality of these patients was studied. In this study serial blood lactate levels was assessed at the time of admission and every six hourly after admission upto 24 hours. They assessed lactate values and lactate associated parameters that is lactate clearance and lactate area. The study concluded, that, blood lactate values and also lactate associated parameters were potentially very useful markers of mortality. In the present study, only serum lactate values was assessed and not lactate associated parameters. The above study did not correlate with the PRISM III scores.

Limitation(s)

The sample size is small. Blood lactate is very unstable when exposed to atmospheric temperature, hence immediate processing of the sample has to be done to avoid errors in the values.

Conclusion

Monitoring of patients admitted to PICU on the basis of PRISM III score and lactate levels is beneficial for the overall outcome and should be incorporated into early resuscitation strategies. As early recognition of shock and aggressive intervention has a better outcome.

Acknowledgement

We are grateful to Dr. Chethan (Statistician) for helping us with the statistical analysis. We are grateful to the laboratory services in R L Jalappa Hospital, Kolar for helping us in timely processing of the samples and obtaining results.

References

1.
Kim YA, Ha EJ, Jhang WK, Park SJ. Early blood lactate area as a prognostic marker in paediatric septic shock: Intensive Care Med. 2013;39:1818-23. [crossref] [PubMed]
2.
Bai Z, Zhu X, Li M, Hua J, Li Y, Pan J, et al. Effectiveness of predicting in hospital mortality in critically ill children by assessing blood lactate levels at admission. BMC Paediatrics. 2014;14:83-91. [crossref] [PubMed]
3.
Choudhary J, Roul Ray SS, Dash LD. Effectiveness of predicting outcomes in septic shock in critically ill children by assessing serum lactate levels. Paediatric Rev Ind J Paediatr Res. 2016;3:09-12. [crossref]
4.
Munde A, Kumar N, Beri RS, Puliyel JM. Lactate clearance as a marker of mortality in PICU. Indian Paediatrics. 2014;51:565-67. [crossref] [PubMed]
5.
Morris KP, McShane P, Stickley J, Parslow RC. The relationship between blood lactate concentration, the Paediatric Index of Mortality 2 (PIM2) and mortality in paediatric intensive care. Intensive Care Medicine. 2012;38:2042-46. [crossref] [PubMed]
6.
Jansen TC, van Bommel J, Schoonderbeek FJ, Sleeswijk Visser SJ, van der Klooster JM, et al. Early lactate-guided therapy in intensive care unit patients: A multicenter, open-label, randomized controlled trial. American Journal of Respiratory and Critical Care Medicine. 2010;182:752-61. [crossref] [PubMed]
7.
Epstein D, Randall CW. Cardiovascular physiology and shock. Nichols DG, ed. Critical Heart Disease in Infants and Children. 2nd ed. Philadelphia, PA: Mosby Elsevier; 2006. 17-72. [crossref]
8.
Nadel S, Kissoon N, Ranjit S. Recognition and initial management of shock. Nichols DG. Roger’s Textbook of Paediatric Intensive Care. Philadelphia, PA: Lippincott, William & Wilkins; 2008. 372-83.
9.
Kleigman RM, Stanton BF, Schor NF, St Geme JW, Beherman RE. The acutely ill child. Nelson Textbook of paediatrics (vol 1) 20th ed. South East Asia: Elsiever 2019;516-528.
10.
Shaw KN, Bachur RG. Resuscitation and Stabilization. Paediatric Emergency Medicine. 7th ed. Philadelphia: Wolters Kluwer 2016;55-69.
11.
Nazir M, Wani W, Dar SA, Mir IH, Charoo BA, Ahmad QI, et al. Lactate clearance prognosticates outcome in paediatric septic shock during first 24 h of intensive care unit admission: Journal of the Intensive Care Society. 2019;175-80. [crossref] [PubMed]
12.
Jat KR, Jhamb U, Gupta VK. Serum Lactate levels as predictor of outcome in paediatric septic shock. Indian J Crit Care Med. 2011;15:102-07. [crossref] [PubMed]
13.
Bakker J, Erasmus MC, Jansen TC. Lactate monitoring in the ICU. Newgen 2016;139:644-48.
14.
Aramburo A, Todd J, George EC, Kiguli S, Olupot PO, Opoka RO. Lactate clearance as a prognostic marker of mortality in severely ill febrile children in East Africa : BMC Medicine. 2018;16:16-37. [crossref] [PubMed]
15.
Gorgis N, Asselin JM, Cynthia F, Scott R, Flori HR, Ward SL. Evaluation of the association of early lactates with outcomes in children with severe sepsis or septic shock. Paediatric Emergency Medicine. 2017;234:345-67. [crossref] [PubMed]
16.
Siddiqui I, Jafri L, Abbas Q, Raheem A, Haque AU. Relationship of serum procalcitonin, c-reactive protein, and lactic acid to organ failure and outcome in critically ill paediatric population. Indian J Crit Care Med. 2018;22:91-95. [crossref] [PubMed]
17.
Gunnerson KJ, Saul M, He S, Kellum JA. Lactate versus non-lactate metabolic acidosis: A retrospective outcome evaluation of critically ill patients. Crit Care. 2006;10(1):R22. [crossref] [PubMed]
18.
Slater A, Shann F. The suitability of the Paediatric Index of Mortality (PIM), PIM2, the Paediatric Risk of Mortality (PRISM), and PRISM III for monitoring the quality of paediatric intensive care in Australia and New Zealand : Paediatric Critical Care Medicine. 2004;5:447-53. [crossref] [PubMed]
19.
Bilan N, Galehgolab BA, Emadaddin A, Shiva SH. Risk of mortality in paediatric intensive care unit, assessed by PRISM-III. Pakistan Journal of Biological Sciences. 2009;12:480. [crossref] [PubMed]
20.
Gonçalves JP, Severo M, Rocha C, Jardim J, Mota T, Ribeiro A. Performance of PRISM III and PELOD-2 scores in a paediatric intensive care unit. European Journal of Paediatrics. 2015;174:1305-10. [crossref] [PubMed]
21.
Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated Paediatric Risk of Mortality score: Critical Care Medicine. 1996;24:743-52. [crossref] [PubMed]

DOI and Others

DOI: 10.7860/JCDR/2022/50903.16006

Date of Submission: Jun 15, 2021
Date of Peer Review: Jul 22, 2021
Date of Acceptance: Oct 04, 2021
Date of Publishing: Feb 01, 2022

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Jun 16, 2021
• Manual Googling: Sep 18, 2021
• iThenticate Software: Sep 28, 2021 (24%)

ETYMOLOGY: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com